Citations

Showing 10 of 108152 citations.

RITAN: rapid integration of term annotation and network resources
Zimmermann, Michael T. , Kabat, Brian, Grill, Diane E. , Kennedy, Richard B. , Zimmermann, Michael T , Kennedy, Richard , Poland, Gregory A.

Mayo Clinic

PeerJ | July 19, 2019 | Volume: 7 | Issue: No issue available | Pages: e6994

10.7717/peerj.6994 | PMID 31355053 Get It

Background Identifying the biologic functions of groups of genes identified in high-throughput studies currently requires considerable time and/or bioinformatics experience. This is due in part to each resource housed within separate databases, requiring users to know about them, and integrate across them. Time consuming and often repeated for each study, integrating across resources and merging with data under study is an increasingly common bioinformatics task. Methods We developed an open-source R software package for assisting researchers in annotating their genesets with functions, pathways, and their interconnectivity across a diversity of network resources. Results We present rapid integration of term annotation and network resources (RITAN) for the rapid and comprehensive annotation of a list of genes using functional term and pathway resources and their relationships among each other using multiple network biology resources. Currently, and to comply with data redistribution policies, RITAN allows rapid access to 16 term annotations spanning gene ontology, biologic pathways, and immunologic modules, and nine network biology resources, with support for user-supplied resources; we provide recommendations for additional resources and scripts to facilitate their addition to RITAN. Having the resources together in the same system allows users to derive novel combinations. RITAN has a growing set of tools to explore the relationships within resources themselves. These tools allow users to merge resources together such that the merged annotations have a minimal overlap with one another. Because we index both function annotation and network interactions, the combination allows users to expand small groups of genes using links from biologic networks—either by adding all neighboring genes or by identifying genes that efficiently connect among input genes—followed by term enrichment to identify functions. That is, users can start from a core set of genes, identify interacting genes from biologic networks, and then identify the functions to which the expanded list of genes contribute. Conclusion We believe RITAN fills the important niche of bridging the results of high-throughput experiments with the ever-growing corpus of functional annotations and network biology resources. Availability Rapid integration of term annotation and network resources is available as an R package at github.com/MTZimmer/RITAN and BioConductor.org .
Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci
Zhang, Peng , Tillmans, Lori S. , Thibodeau, Stephen N. , Wang, Liang , Wang, Liang

Mayo Clinic

Genes | July 19, 2019 | Volume: 10 | Issue: 7 | Pages: 547

10.3390/genes10070547 | PMID 31323811 Get It

Genome-wide association studies have identified over 150 risk loci that increase prostate cancer risk. However, few causal variants and their regulatory mechanisms have been characterized. In this study, we utilized our previously developed single-nucleotide polymorphisms sequencing (SNPs-seq) technology to test allele-dependent protein binding at 903 SNP sites covering 28 genomic regions. All selected SNPs have shown significant cis-association with at least one nearby gene. After preparing nuclear extract using LNCaP cell line, we first mixed the extract with dsDNA oligo pool for protein–DNA binding incubation. We then performed sequencing analysis on protein-bound oligos. SNPs-seq analysis showed protein-binding differences (>1.5-fold) between reference and variant alleles in 380 (42%) of 903 SNPs with androgen treatment and 403 (45%) of 903 SNPs without treatment. From these significant SNPs, we performed a database search and further narrowed down to 74 promising SNPs. To validate this initial finding, we performed electrophoretic mobility shift assay in two SNPs (rs12246440 and rs7077275) at CTBP2 locus and one SNP (rs113082846) at NCOA4 locus. This analysis showed that all three SNPs demonstrated allele-dependent protein-binding differences that were consistent with the SNPs-seq. Finally, clinical association analysis of the two candidate genes showed that CTBP2 was upregulated, while NCOA4 was downregulated in prostate cancer (p < 0.02). Lower expression of CTBP2 was associated with poor recurrence-free survival in prostate cancer. Utilizing our experimental data along with bioinformatic tools provides a strategy for identifying candidate functional elements at prostate cancer susceptibility loci to help guide subsequent laboratory studies.
Some Problems in Diagnosis and their Solution by Radiologic Examination of the Alimentary Canal
Kirklin, B. R.

Mayo Clinic

Proceedings of the Royal Society of Medicine | July 19, 2019 | Volume: 28 | Issue: 5 | Pages: 549-563

10.1177/003591573502800536 | PMID 19990218 Get It

The Medical Management of Chronic Ulcerative Colitis
Bargen, J. Arnold

Mayo Clinic

Proceedings of the Royal Society of Medicine | July 19, 2019 | Volume: 30 | Issue: 4 | Pages: 351-362

10.1177/003591573703000402 | PMID 19990979 Get It

Samuel Hyde Memorial Lecture
Krusen, Frank H.

Mayo Clinic

Proceedings of the Royal Society of Medicine | July 19, 2019 | Volume: 43 | Issue: 8 | Pages: 641-658

10.1177/003591575004300811 | PMID 14776151 Get It

Discussion on the Repair of Injuries to the Common Bile Duct
Gray, Howard K.

Mayo Clinic

Proceedings of the Royal Society of Medicine | July 19, 2019 | Volume: 44 | Issue: 12 | Pages: 1005-1012

10.1177/003591575104401204 | PMID 14911835 Get It

Is Obesity an Endocrine Problem? [ Abstract ]
Rynearson, Edward H.

Mayo Clinic

Proceedings of the Royal Society of Medicine | July 19, 2019 | Volume: 44 | Issue: 11 | Pages: 951-952

10.1177/003591575104401111 | PMID 19993787 Get It

The Pancreas [ Abridged ]
Hermon-Taylor, John

Mayo Clinic

Proceedings of the Royal Society of Medicine | July 19, 2019 | Volume: 63 | Issue: 5 | Pages: 436-436

10.1177/003591577006300504 | PMID 4916563 Get It

Prevalence of sleep disorders in Parkinson’s disease patients in two Neurology referral hospitals in Ethiopia
Melka, Dereje , Tafesse, Abenet , Bower, James H., Assefa, Demeke

Mayo Clinic

No container title available | July 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.442/v3 Get It

Abstract Background: Non motor symptoms (NMS) of Parkinson’s disease (PD) are common and can be more disabling than motor symptoms.Sleep disorders can be seen in up to 98% of patients with Parkinson disease. Poor sleep quality has been associated with poverty and race, and yet there has been no prior report on sleep disorders in those with PD living in sub Saharan Africa. We wished to document the prevalence of sleep disorders in PD patients in Ethiopia. Methods: We conducted a cross-sectional point prevalence study from July 1 to October 30, 2015 of all patients attending the neurology outpatient department in Tikur Anbessa and Zewuditu Memorial Hospitals, Addis Ababa, Ethiopia. Demographic data, clinical history and physical examination findings were collected from participants using a structured questionnaire. We used the Parkinson’s disease sleep scale version two (PDSS-2) and Epworth Sleepiness Scale (ESS) to assess the sleep symptoms. Results: Of the 155 patients surveyed, all patients reported some sleep problem. Over 43.9% of patients had a PDSS score > 18. The median score of ESS was 9 (IQR = 5-12), with 77/155 (49.7%) of the patients having possible or definite excessive daytime somnolence. A high EDSS score significantly associated with a Hoehn & Yahr score > 4 (p= 0.02). Conclusions: In Ethiopian PD patients, the prevalence of those with severe sleep disorders is the highest reported to date. The prevalence of possible/definite EDS is amongst the highest in the world. Further investigation into whether poverty or race explains this finding is needed.
Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma
Hinze, Alicia M. , Lin, Cheng Ting , Hussien, Amira , Perin, Jamie , Venado, Aida , Boin, Francesco , Brown, Robert H. , Wigley, Fredrick M. , Hinze, Alicia M , Golden, Jeffrey A , Wise, Robert A.

Mayo Clinic

Rheumatology | July 18, 2019 | Volume: 59 | Issue: 4 | Pages: 790-798

10.1093/rheumatology/kez341 | PMID 31504916 Get It

Abstract Objective To investigate the natural history of fibrotic lung disease in recipients of a single lung transplant for scleroderma-associated interstitial lung disease (ILD). Methods Global ILD (including ground glass, nodular opacities and fibrosis) was categorized into severity quintiles on first and last post-transplant CT scans, and percent fibrosis by manual contouring was also determined, in nine single lung transplant recipients. Quantitative mean lung densities and volumes for the native and allograft lungs were also acquired. Results In the native lung, global ILD severity quintile worsened in two cases and percent fibrosis worsened in four cases (range 5–28%). In the lung allograft, one case each developed mild, moderate and severe ILD; of these, new fibrotic ILD (involving &lt;10% of lung) occurred in two cases and acute cellular rejection occurred in one. The average change in native lung density over time was +2.2 Hounsfield Units per year and lung volume +1.4 ml per year, whereas the allograft lung density changed by –5.5 Hounsfield Units per year and total volume +27 ml per year (P = 0.011 and P = 0.039 for native vs allograft density and volume comparisons, respectively). Conclusions While the course of ILD in the native and transplanted lungs varied in this series, these cases illustrate that disease progression is common in the native lung, suggesting that either the immune process continues to target autoantigens or ongoing fibrotic pathways are active in the native lung. Mild lung disease may occur in the allograft after several years due to either allograft rejection or recurrent mild ILD.